TuxCare and DOSIsoft Partner to Offer Ongoing Support, Protections for Radiation Oncology and Nuclear Medicine Software

May 21, 2024 10:05 PM AEST | By EIN Presswire
 TuxCare and DOSIsoft Partner to Offer Ongoing Support, Protections for Radiation Oncology and Nuclear Medicine Software
Image source: EIN Presswire

Hospitals worldwide to be offered extended lifecycle support and security alongside five DOSIsoft solutions PALO ALTO, CALIF., USA, May 21, 2024 /EINPresswire.com/ -- TuxCare, a global innovator in enterprise-grade cybersecurity for Linux, today announced an OEM partnership with France-based DOSIsoft, a leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear medicine.

Under the partnership, TuxCare’s Extended Lifecycle Support (ELS) for CentOS 7 is included in five DOSIsoft offerings. As a cutting-edge innovator known for its strong expertise in dosimetry, DOSIsoft prioritizes cybersecurity while also maintaining operational efficiency for its analysis and calculation products. Its CentOS 7 systems, including MU2net, EPIbeam, EPIgray®, PLANET® Onco Dose and ThinkQA2 solutions, now benefit from the peace of mind provided by TuxCare’s ELS service that make’s CentOS 7’s upcoming end of life a non-event for users.

“We’re pleased to partner with a market leader such as DOSIsoft to help ensure uninterrupted and ongoing operations as well as top-notch cybersecurity for hospitals spanning the globe,” said Michael Canavan, Chief Revenue Officer at TuxCare. “This partnership creates notable value for DOSIsoft customers and eliminates concerns surrounding the end of life of such core systems that are depended upon to provide vital patient care.”

“Thanks to this partnership with TuxCare, DOSIsoft will be able to provide continuous best-in-class cybersecurity, support and compliance for its CentOS 7-based medical devices during the next 5 years,” said Marc Uszynski, CEO at DOSIsoft. “In the short term, our key partners, distributors and end-user clinical centers will benefit from uninterrupted support with enhanced cybersecurity ensured with TuxCare ELS Complete services. In a mid-term plan, this partnership and services enable us to control migration to a new operating system as part our product R&D plans for both our patient-specific quality assurance ThinkQA suite for radiation therapy and our PLANET® Dosimetry solution for molecular radiation therapy.”

About DOSIsoft
Founded in 2002, DOSIsoft designs, develops & delivers patient-specific imaging & dosimetry software solutions in radiation oncology and nuclear medicine to improve cancer patient safety & treatment quality. More than 20 years of innovation and R&D investments have led to world-leading software used in over 600 hospital centers in 60 countries. A spin-off between Gustave Roussy and Institut Curie, DOSIsoft constantly innovates in partnership with the major cancer institutes and research centers in the world. Visit www.dosisoft.com.

About TuxCare
TuxCare is on a mission to reduce the world’s risk of cyber exploitation. Through its automated live security patching solutions and extended lifecycle support services for Linux and open source software and languages, TuxCare allows thousands of organizations to rapidly remediate vulnerabilities for increased security and compliance. The world’s largest enterprises, government agencies, service providers, universities, and research institutions are protected by TuxCare on over one million workloads and growing. For more information, go to https://tuxcare.com.

DOSIsoft Contact:
[email protected]

TuxCare Contact:

DeShea Witcher
TuxCare
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.